ALTHEIA SCIENCE
Altheia Science is an Italian biotech company that aims to help patients with autoimmune diseases through cell and gene therapies.Altheia Science is transforming the life of patients with autoimmune diseases throught innovative and curative cell and gene therapies.
ALTHEIA SCIENCE
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Milano, Lombardia, Italy
Country:
Italy
Website Url:
http://www.altheiascience.com
Total Employee:
1+
Status:
Active
Contact:
+39 02 495 334 10
Total Funding:
11 M USD
Technology used in webpage:
Euro JsDelivr Google BootstrapCDN
Similar Organizations
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Elstar Therapeutics
Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Rottapharm Biotech
Rottapharm Biotech investment in Series A - Altheia Science
Official Site Inspections
http://www.altheiascience.com Semrush global rank: 8.82 M Semrush visits lastest month: 461
- Host name: 153.197.214.35.bc.googleusercontent.com
- IP address: 35.214.197.153
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Altheia Science"
Altheia Science: Towards curative medicine
US Office: The Empire State Building 350 Fifth Avenue Suite 7530 New York, NY 10118See details»
About Us - Altheia Science
The Way of the Rain, a non profit organization run by Sibylle and Robert Redford which is organized exclusively for charitable , cultural and educational purposes , including the specific …See details»
Altheia Science - Crunchbase Company Profile & Funding
Altheia Science is an Italian biotech company that aims to help patients with autoimmune diseases through cell and gene therapies.Altheia Science is …See details»
Altheia Science - LinkedIn
Altheia Science is a pioneering start-up founded by two world renowned Italian scientists, Prof. Alessandra Biffi, MD and Prof. Paolo Fiorina, MD, PhD, together with AurorA-TT.See details»
Altheia Science Company Profile - Office Locations, Competitors
Altheia Science has 5 employees across 2 locations and $11 m in total funding,. See insights on Altheia Science including office locations, competitors, revenue, financials, executives, …See details»
Altheia Science - PitchBook
Altheia Science General Information Description. Developer of cell and gene therapeutics intended for the treatment of autoimmune diseases and liquid tumors. The company focuses …See details»
Altheia Science - 2025 Company Profile - Tracxn
Mar 9, 2025 Altheia Science - Developer of stem cell-based therapeutics for cancer and autoimmune diseases. Raised a total funding of $19.3M over 1 round from 2 investors. …See details»
Pipeline - Altheia Science
US Office: The Empire State Building 350 Fifth Avenue Suite 7530 New York, NY 10118See details»
Altheia Science - EU-Startups
Altheia Science is a pioneering start-up founded by two world renowned Italian scientists, Prof. Alessandra Biffi, MD and Prof. Paolo Fiorina, MD, PhD, together with AurorA-TT.See details»
Altheia Science - Overview, News & Similar companies - ZoomInfo
Jul 28, 2022 View Altheia Science (www.altheiascience.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Altheia Sciences - VentureRadar
Website: https://altheiascience.com/ Altheia Science’s pipeline exploits pioneering therapeutic tools for autoimmune diseases and cancer. The modulation of PD-L1 ...See details»
Altheia Science Overview | SignalHire Company Profile
Altheia Science is a private company that has been in the industry for 6 years. The company currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas. The position …See details»
Altheia Science press release 19 dec 2018
Dec 19, 2018 C.F. / P.IVA 10128260964 e-mail: [email protected] PEC: [email protected] web: www.altheiascience.com She published over 65 peer …See details»
Altheia Science - Products, Competitors, Financials, Employees ...
Altheia Science is a biotechnology company focused on developing cell and gene therapies for patients with autoimmune diseases and cancer. Use the CB Insights Platform to explore …See details»
Altheia Science Reviews, Funding, Founder, Valuation & Jobs
Find out if Altheia Science is hiring now! Explore jobs, salary, equity, funding, founder, and valuationn information. Read about work-life balance, perks, benefits, and the company culture!See details»
AGC Biologics Supports Altheia Science’s Gene Therapy
Jul 28, 2022 To learn more, visit www.altheiascience.com. About AGC Biologics AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization …See details»
AGC Biologics Supports Altheia Science’s Gene Therapy Programs
Jul 27, 2022 Global CDMO announces new development partnership with Altheia Science, a gene therapy company pioneering cell and gene therapy strategies to treat autoimmune …See details»
Altheia Sciences - VentureRadar
Similar Companies: Kolon Life Science South Korea Privately Held Kolon is a pioneering company in the field of cell and gene therapy, focusing on research and development to …See details»
Patients & Families - Altheia Science
US Office: The Empire State Building 350 Fifth Avenue Suite 7530 New York, NY 10118See details»
Our technology - Altheia Science
PD-L1 and autoimmune disorders . Programmed death-ligand 1 (PD-L1) is a checkpoint molecule involved in the control of reactive T cells. Harnessing the power of the immune-regulatory …See details»